David F. Kisor, PharmD, RPh, FCP has more than 35 years of academic and industry experience. He has extensive expertise in pharmacogenomics related to the application of genetics to pharmacokinetics and precision/personalized medicine as well as applications of genetics to medication selection and dosing. Dr. Kisor’s application of pharmacogenomics spans across many therapeutic areas. Dr. Kisor has authored and/or co-authored more than 50 peer-reviewed papers, three peer-reviewed books, several book chapters, and NDAs, IBs, and protocols. Dr. Kisor also directs the pharmacogenomics program at Manchester University.